ES2109268T3 - 5h-dibenzo(a,d)cicloheptenos utilizados como antagonistas de receptores muscarinicos. - Google Patents

5h-dibenzo(a,d)cicloheptenos utilizados como antagonistas de receptores muscarinicos.

Info

Publication number
ES2109268T3
ES2109268T3 ES91911520T ES91911520T ES2109268T3 ES 2109268 T3 ES2109268 T3 ES 2109268T3 ES 91911520 T ES91911520 T ES 91911520T ES 91911520 T ES91911520 T ES 91911520T ES 2109268 T3 ES2109268 T3 ES 2109268T3
Authority
ES
Spain
Prior art keywords
dibenzo
cyclloheptenes
receptor antagonists
muscarinic receptor
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91911520T
Other languages
English (en)
Inventor
Marcel Hibert
Hijfte Luc Van
Mary Richards
Paul Moser
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2109268T3 publication Critical patent/ES2109268T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/03—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/31—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring the six-membered aromatic ring being part of a condensed ring system formed by at least three rings
    • C07C211/32—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring the six-membered aromatic ring being part of a condensed ring system formed by at least three rings containing dibenzocycloheptane or dibenzocycloheptene ring systems or condensed derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/30—Ortho- or ortho- and peri-condensed systems containing three rings containing seven-membered rings
    • C07C2603/32—Dibenzocycloheptenes; Hydrogenated dibenzocycloheptenes

Abstract

LA INVENCION SE REFIERE A NUEVOS 5H-DIBENZO[A,D]CICLOHEPTANOS, A PROCESOS PARA SU PREPARACION, A SUS PROPIEDADES ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS Y A SU USO EN APLICACIONES PARA TRATAR LA ENFERMEDAD DE PARKINSON, LA DISNESIA TARDIA, Y LAS ENFERMEDADES DEL MOVIMIENTO.
ES91911520T 1990-05-18 1991-04-25 5h-dibenzo(a,d)cicloheptenos utilizados como antagonistas de receptores muscarinicos. Expired - Lifetime ES2109268T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90401332 1990-05-18

Publications (1)

Publication Number Publication Date
ES2109268T3 true ES2109268T3 (es) 1998-01-16

Family

ID=8205710

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91911520T Expired - Lifetime ES2109268T3 (es) 1990-05-18 1991-04-25 5h-dibenzo(a,d)cicloheptenos utilizados como antagonistas de receptores muscarinicos.

Country Status (6)

Country Link
EP (1) EP0581767B1 (es)
JP (1) JPH05508399A (es)
AU (1) AU7957191A (es)
DE (1) DE69127549T2 (es)
ES (1) ES2109268T3 (es)
WO (1) WO1991017973A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5508280A (en) * 1990-05-18 1996-04-16 Merrell Pharmaceuticals, Inc. 5H-Dibenzo (A,D) cycloheptenes as muscarinic receptor antagonists
GB9400600D0 (en) * 1994-01-14 1994-03-09 Pfizer Ltd Treatment of motion seckness
KR100700440B1 (ko) 2005-01-14 2007-03-27 네오뷰코오롱 주식회사 청색 발광 유기 화합물 및 이를 포함하는 유기 발광다이오드

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA958643A (en) * 1970-07-07 1974-12-03 Frosst (Charles E.) And Co. Pharmaceutical compositions containing cyclobenzaprine
US3828034A (en) * 1972-05-25 1974-08-06 Syntex Inc Tricyclic pharmacological agents,intermediates and methods of making
ES8502099A1 (es) * 1983-08-02 1984-12-16 Espanola Farma Therapeut Procedimiento de obtencion de nuevos compuestos derivados de la difenil-metilen-etilamina.

Also Published As

Publication number Publication date
EP0581767B1 (en) 1997-09-03
WO1991017973A1 (en) 1991-11-28
AU7957191A (en) 1991-12-10
JPH05508399A (ja) 1993-11-25
EP0581767A1 (en) 1994-02-09
DE69127549D1 (de) 1997-10-09
DE69127549T2 (de) 1998-04-23

Similar Documents

Publication Publication Date Title
ES2159738T3 (es) Derivados de benzamida y su uso como antagonistas de vasopresina.
ES2151652T3 (es) Derivados de indol como antagonistas del receptor 5ht.
ES2194265T3 (es) Derivados de piperidino 4-carboxamida y su utilizacion como antagonistas de la neuroquinina.
AR026275A1 (es) Compuestos farmaceuticos
AR004516A1 (es) Derivados de pirimidina, su uso, procedimientos para prepararlos y medicamentos que los contienen
UY27760A1 (es) Nuevos derivados de pirrolidinio.
ES2091877T3 (es) Uso de antagonistas de la angiotensina ii para la fabricacion de un medicamento para el tratamiento de la hiperuricemia.
PT101038A (pt) Derivados de indano e indeno, seu processo de preparacao, composicoes farmaceuticas e seu uso como antagonistas do receptor de endotelina
AR006119A1 (es) Compuestos de quinoxalinadionas uso de los mismos para la fabricacion de un medicamento, compuestos de quinoxalinas para producirlos y procedimiento parala preparacion de los mismos
ES2053451T3 (es) Un procedimiento para la preparacion de un compuesto que tiene propiedades farmacologicas utiles.
ES2144412T3 (es) Derivados de bencimidazoles como antagonistas de 5-ht1a y 5ht2.
ES2128735T3 (es) Composiciones farmaceuticas que comprenden un antagonista de opiaceos y de sales de calcio y su uso para el tratamiento de patologias en las que intervienen las endorfinas.
CO5011096A1 (es) Medicamentos que contienen antagonistas del receptor 5-ht3 para el tratamiento de la ibs
PA8434601A1 (es) Ciertos derivados de la bencilamina amido- y aminosustituidos;una nueva clase de ligandos especificos del neuropeptido y1.
ES2054872T3 (es) Nuevos derivados de acido bencimidazolin-2-oxo-1-carboxilico utiles como antagonistas de los receptores 5-ht.
AR002268A1 (es) Antagonistas de vasopresina de benzacepina triciclicos, un procedimiento para su preparacion, una composicion farmaceutica que los contiene y el uso dedichos compuestos para preparar composiciones farmaceuticas.
ES2127524T3 (es) Derivados de benzamida como antagonistas de vasopresina.
BR9809491A (pt) "derivados de ergolina e seu uso como antagonista de receptor de somatostatina"
UY26601A1 (es) Antagonistas de los receptores de il-8
ES2043665T3 (es) 6,11-dihidro-11-(4-piperidiliden)-5h-benzo-(5,6)-ciclohepta-(1,2-b)-piridinas y composiciones y metodos de uso.
BR0111301A (pt) Cicloexilaminas bicìclicas e seu uso como antagonistas de receptor de nmda
ES2109268T3 (es) 5h-dibenzo(a,d)cicloheptenos utilizados como antagonistas de receptores muscarinicos.
ES2115220T3 (es) Nuevo uso de compuestos bis-heterociclicos como agentes antiinflamatorios y composiciones farmaceuticas de los mismos.
AR002704A1 (es) 2-(2-n-alcoxifenil)-purin-6-onas 9-sustituidas, procedimiento para su preparacion, composiciones farmaceuticas que las contienen y su uso parapreparar composiciones farmaceuticas.
AR028743A1 (es) DERIVADOS DE N-TRIAZOLILMETIL-PIPERAZINA CON ACCIoN ANTAGONISTA DE RECEPTORES DE NEUROQUININA

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 581767

Country of ref document: ES